Clinical trials
Squamous Cell Carcinoma of Head and Neck trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2019 | 2 |
| 2021 | 3 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 10 |
| Unknown status | 5 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tata Memorial Hospital | 4 |
| AstraZeneca | 3 |
| All India Institute of Medical Sciences | 2 |
| GlaxoSmithKline | 2 |
| Kolhapur Cancer Centre - Cancer Centers of America | 2 |
| Piramal Enterprises Limited | 2 |
| Bicara Therapeutics | 1 |
| CEL-SCI Corporation | 1 |
| Cancer Research UK | 1 |
| Dr.Pankaj Chaturvedi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 30 |
| Head and Neck Neoplasms | 10 |
| Mouth Neoplasms | 8 |
| Carcinoma, Squamous Cell | 3 |
| Neoplasms, Squamous Cell | 2 |
| Camurati-Engelmann Syndrome | 1 |
| Carcinoma in Situ | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Renal Cell | 1 |
| Endometrial Neoplasms | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.